Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Antifungal Prophylaxis With Posaconazole.

NCT03434704 is registered in ClinicalTrials.gov with Ciceri Fabio as lead sponsor.

NCT NCT03434704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03434704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Antifungal Prophylaxis With Posaconazole.
Lead sponsor
Ciceri Fabio
Phase
Phase 2
Overall status
Completed
Start date
June 18, 2018
Completion date
October 13, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fungal infection, graft vs host disease, leukemia, acute, myelodysplastic syndromes, transplant-related hematologic malignancy